Kaitlyn D’Onofrio

DocwireNews

Here are the top stories recently covered by DocWire News in the rheumatology section. In this edition, read about the increased risk for comorbidities in osteoarthritis patients, outcomes for black knee arthroplasty patients, exercise in women with osteoporosis after vertebral fracture, and more.<a href="https://www.docwirenews.com/docwire-pick/rheumatology-picks/comorbidities-including-hypertension-are-more-common-among-oa-patients/">Patients with osteoarthritis (OA) are at a greater risk of suffering from comorbidities</a> compared to the general population, a study suggests. A total of 42 studies from 16 countries were included for review. The pooled prevalence ratio (PR) for any comorbidity was 1.21 (95% CI, 1.02 to 1.45); the PR increased with the number of comorbidities. For one comorbidity, the PR was 0.73 (95% CI, 0.43 to 1.25); for two, the PR was 1.58 (95% CI, 1.03 to 2.42); and for three or more comorbidities, the PR was 1.94 (95% CI, 1.45 to 2.59).<a href="https://www.docwirenews.com/condition-center/orthopedicscc/orthopedics-center-picks/researchers-assess-short-term-risk-factors-for-adverse-events-in-black-tka-patients/">A recent study evaluated time trends and risk factors</a> for 30-day adverse events (AEs) among black patients who undergo total knee arthroplasty (TKA). The analysis included 19,496 black TKA patients treated during the study period, during which time comorbidity profiles improved, length of stay decreased, and the rate of AEs was reduced. Risk factors associated with AEs were male gender, tobacco smoking, American Society of Anesthesiologists score &gt;2, dependent functional status, congestive heart failure, chronic obstructive pulmonary disease, metastatic cancer, dyspnea, chronic kidney disease, bilateral TKA, and operative time &gt;100 minutes.<a href="https://www.docwirenews.com/condition-center/orthopedicscc/orthopedics-center-picks/exercise-may-be-beneficial-for-women-with-osteoporosis-following-vertebral-fracture/">A study evaluated the effects of exercise on women</a> with osteoporosis and vertebral fracture and observed improvements in muscle strength, balance, and mobility, and less of a fear of falling. This was a follow-up study that took place three months after an intervention as part of a randomized, controlled trial that randomized 149 women aged 65 years or older with osteoporosis and vertebral fracture to either an exercise or control group. At the three-month post-intervention follow-up, the mean between-group difference in habitual walking speed was not statistically significant. However, physical fitness outcomes differed and significantly favored the exercise group, including balance, arm curl, leg strength, and mobility. The exercise group also had a significantly lower fear of falling.<a href="https://www.docwirenews.com/condition-center/orthopedicscc/orthopedics-center-picks/ibuprofen-does-not-delay-fracture-healing-in-pediatric-patients-study-finds/">Ibuprofen may help manage pain in pediatric fracture cases without delaying healing, according to a study</a>. Final analysis included 95 patients (97 fractures) who completed six months of follow-up: 49 patients (50 fractures) in the nonsteroidal anti-inflammatory drug (NSAID) group and 46 patients (47 fractures) in the control group. None of the patients in either group achieved healing at two weeks. At six weeks, a greater proportion of patients in the NSAID group achieved healing than the control group. At 10- to 12-week follow-up, all fractures in the ibuprofen group and 98% in the control group were healed; at six months, all fractures were completely healed. The mean time to healing in the ibuprofen group was 31 days and in the control group was 40 days. Breakthrough oxycodone was used a mean 1.9 days in the NSAID group and 2.4 days in the control group.<a href="https://www.docwirenews.com/docwire-pick/rheumatology-picks/joint-and-skin-symptoms-make-quality-of-life-significantly-worse-for-psoriatic-arthritis-patients/">A study ascertained the effect of joint and skin symptoms</a> on psoriatic arthritis (PsA) patients and found that they contribute significantly to poorer clinical outcomes, health-related quality of life, and work productivity, compared to patients with only joint symptoms. Data from 2,703 patients were included. About two-thirds of patients (64.5%) had joint and skin involvement. The mean tender joint count was higher for joint and skin involvement patients than joint only patients (5.2 vs. 2.0), as was the mean swollen joint count (4.8 vs. 1.5). Twelve-month flare history was significantly more prevalent among active joint and skin symptoms patients versus joint only patients (34.9% vs. 23.2%; P&lt;0.001). More patients prioritized symptom burden pertaining to joints than skin (61.6% vs. 38.4%). About two in 10 patients (41.4%) experienced anxiety depression; of these patients, about two-thirds (62.4%) attributed it to both skin and joint symptoms.

Areef Ishani, MD

Joel M. Topf, MD, FACP

Kidney Stones With Chlorthalidone Versus Hydrochlorothiazide

NKF Spring Clinical Meetings 2025

MarkAlain Déry, DO

Eric Griggs, MD

Measles in America: An Ongoing Problem

Infectious Disease

Roger Rodby, MD

Seldin Award Winner Advocates Online Education

Latest News

Rheum Round-up: Comorbidities in OA, Racial Disparities in TKA Outcomes, and more

Rheumatology

Here are the top stories recently covered by DocWire News in the rheumatology section. In this edition, read about the increased risk for comorbidities in osteoarthritis ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe